GlaxoSmithKline PLC  

(Public, ETR:GS7)   Watch this stock  
Find more results for GS7
-0.26 (-1.45%)
Delayed:   3:54PM GMT+1
ETR data delayed by 15 mins - Disclaimer
Currency in EUR
Range 17.08 - 17.52
52 week 16.64 - 22.90
Open 17.44
Vol / Avg. 66,336.00/44,085.00
Mkt cap     -
P/E     -
Div/yield     -
EPS     -
Shares 1.00
Beta     -
Inst. own     -
May 6, 2016
GlaxoSmithKline PLC Annual Shareholders Meeting (Estimated) - 3:30PM GMT+2 - Add to calendar
Apr 27, 2016
Q1 2016 GlaxoSmithKline PLC Earnings Release Add to calendar
Feb 10, 2016
GlaxoSmithKline PLC at Leerink Partners Global Healthcare Conference
Feb 3, 2016
Q4 2015 GlaxoSmithKline PLC Earnings Call
Feb 3, 2016
Q4 2015 GlaxoSmithKline PLC Earnings Release
Jan 12, 2016
GlaxoSmithKline PLC at JPMorgan Healthcare Conference
Dec 18, 2015
GlaxoSmithKline PLC Buys Bristol-Myers Squibb's HIV Assets - Conference Call


980 Great West Road
United Kingdom - Map
+44-20-80475000 (Phone)
+44-20-80477807 (Fax)

Website links

External links


GlaxoSmithKline plc. (GSK) is a healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products. The Company operates in two segments: Pharmaceuticals and Vaccines, and Consumer Healthcare. The Pharmaceuticals segment develops and makes medicines to treat a range of acute and chronic diseases. Its human immunodeficiency virus (HIV) business is managed through ViiV Healthcare. GSK's Vaccines has a portfolio of over 30 paediatric, adolescent, adult travel vaccines. GSK's Established Products Portfolio includes over 50 off-patent products, as well as its branded generics business and other local products. The Consumer Healthcare business develops and markets products in four categories, such as wellness, oral health, nutrition and skin health. Its brands include Sensodyne, Panadol, Horlicks, Polident, Paradontax, Tums, ENO, NiQuitin/Nicorette, Abreva, Zovirax and Aquafresh. It operates in the United Kingdom, the United States, Belgium and China.

Officers and directors

Andrew Philip Witty Chief Executive Officer, Executive Director
Age: 50
Simon Dingemans Chief Financial Officer, Executive Director
Age: 51
Moncef Slaoui Chairman - Global Vaccines, Executive Director
Age: 55
Roger Connor President - Global Manufacturing & Supply
Abbas Hussain President, Global Pharmaceuticals
Shah Abbas Hussain President - Europe, Japan & EMAP
Age: 49
Patrick Vallance President - Pharmaceuticals R&D
Emma Walmsley President - Consumer Healthcare Worldwide
Daniel Troy Senior Vice President, General Counsel
Claire Thomas Senior Vice President - Human Resources